- Open
- 5520.00
- High
- 5600.00
- Low
- 5459.22
- Close
- 5495.00
- Change
- +70.00 (1.29%)
- Volume
- 40,256
| 9 Oct 2026 | 07:00:02 | Annual Financial Report |
| 29 Sept 2026 | 16:00:00 | Director/PDMR Shareholding |
| 23 Sept 2026 | 07:00:03 | Final Results |
| 11 Sept 2026 | 10:00:00 | Notice of Results |
| 24 Jul 2026 |
| 3 Oct 2025 | Annual Report 2025 | |
| 27 Sep 2024 | Annual Financial Report | |
| 3 Oct 2023 | Annual Report 2023 |
Renishaw PLC designs and manufactures high-precision measurement and manufacturing systems, as well as analytical instruments and medical devices. The company operates through two main segments: Manufacturing Technologies and Analytical Instruments & Medical Devices. Renishaw serves a diverse range of customers across various industries, including engineering, aerospace, and healthcare, primarily in the APAC, EMEA, and Americas regions. Its operations are supported by significant research and development activities, mainly conducted in the UK, with additional manufacturing facilities in Ireland and India.
| 9 Oct 2026 | 07:00:02 | Annual Financial Report |
| 29 Sept 2026 | 16:00:00 | Director/PDMR Shareholding |
| 23 Sept 2026 | 07:00:03 | Final Results |
| 11 Sept 2026 | 10:00:00 | Notice of Results |
| 24 Jul 2026 |
| 3 Oct 2025 | Annual Report 2025 | |
| 27 Sep 2024 | Annual Financial Report | |
| 3 Oct 2023 | Annual Report 2023 |
Renishaw PLC designs and manufactures high-precision measurement and manufacturing systems, as well as analytical instruments and medical devices. The company operates through two main segments: Manufacturing Technologies and Analytical Instruments & Medical Devices. Renishaw serves a diverse range of customers across various industries, including engineering, aerospace, and healthcare, primarily in the APAC, EMEA, and Americas regions. Its operations are supported by significant research and development activities, mainly conducted in the UK, with additional manufacturing facilities in Ireland and India.
| 07:00:03 |
| Trading Statement |
| 15 Oct 2026 |
| London midday: Stocks extend gains despite Asian tech selloff; miners slump |
| 24 Jul 2026 | Renishaw caps year of accelerating growth with record fourth quarter |
| 5 Jun 2026 | Share Sleuth: the firm I’ve bought again despite a pricey valuation |
| 21 May 2026 | Expert View: Renishaw, Babcock, 4imprint, Forterra, and Keller |
| 6 May 2026 | Renishaw reports record Q3 and sustained growth in 9M FY2026 |
| 20 Apr 2026 | UK Stock Market News: Advance Medical Solutions, Kainos, Renishaw |
| 07:00:03 |
| Trading Statement |
| 15 Oct 2026 |
| London midday: Stocks extend gains despite Asian tech selloff; miners slump |
| 24 Jul 2026 | Renishaw caps year of accelerating growth with record fourth quarter |
| 5 Jun 2026 | Share Sleuth: the firm I’ve bought again despite a pricey valuation |
| 21 May 2026 | Expert View: Renishaw, Babcock, 4imprint, Forterra, and Keller |
| 6 May 2026 | Renishaw reports record Q3 and sustained growth in 9M FY2026 |
| 20 Apr 2026 | UK Stock Market News: Advance Medical Solutions, Kainos, Renishaw |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £10.59bn | +0.5% | |
| £7.62bn | +0.1% | |
| £5.50bn | +0.4% | |
RSWRenishaw PLC | £4.00bn | +0.5% |
| £257m | +0.6% | |
| £8m | -0.3% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £10.59bn | +0.5% | |
| £7.62bn | +0.1% | |
| £5.50bn | +0.4% | |
RSWRenishaw PLC | £4.00bn | +0.5% |
| £257m | +0.6% | |
| £8m | -0.3% |
